Background: Infant leukaemia is likely initiated in utero. Methods: We examined whether analgesic use during pregnancy was associated with risk by completing telephone interviews of the mothers of 441 infant leukaemia cases and 323 frequency-matched controls, using unconditional logistic regression. Results: With the exception of a reduced risk for infant acute myeloid leukaemias with non-aspirin non-steroidal anti-inflammatory drugs (NSAID) use early in pregnancy (odds ratios=0.60; confidence intervals: 0.37-0.97), no statistically significant associations were observed for aspirin, non-aspirin NSAIDs, or acetaminophen use in early pregnancy or after knowledge of pregnancy. Conclusion: Overall, analgesic use during pregnancy was not significantly associated with the risk of infant leukaemia. © 2011 Cancer Research UK All rights reserved.
CITATION STYLE
Ognjanovic, S., Blair, C., Spector, L. G., Robison, L. L., Roesler, M., & Ross, J. A. (2011). Analgesic use during pregnancy and risk of infant leukaemia: A Children’s Oncology Group study. British Journal of Cancer, 104(3), 532–536. https://doi.org/10.1038/sj.bjc.6606046
Mendeley helps you to discover research relevant for your work.